עוד רגע
The
Tasty&Healthy study
Inclusion criteria
ACTIVE-RCT-I
ACTIVE-RCT-II
Mild-moderate disease activity (wPCDAI 20-57.5 or CDAI 200-450) or milder disease (wPCDAI 12.5-57.5 or CDAI 150-450)
Clinical remission or at most minimal symptoms (wPCDAI<20/ CDAI<200)
Ages 6-24
Ages 6-40
Disease duration
: less than a year
Disease duration <3 years
MINI≥8 points (FC>600 OR FC>300 and elevated CRP/ESR)
No drugs or maintenance stable treatment IMM/5ASA
No drugs or maintenance stable treatment IMM/5ASA or first biologic
Exclusion criteria for both trials
Fibrostenotic or penetrating phenotype
.
Fistulizing perianal disease which is not in complete remission
.
“
UC-like” isolated Crohn’s colitis
.
Prior failure of exclusive enteral nutrition or any other dietary intervention, for any reason
.
The use of steroids, budesonide or antibiotics prescribed to treat the CD in the recent month
.
Any formula feed during the last month
.
Prior intestinal resection
.
Pregnancy
.
Celiac disease
.
For ACTIVE-RCT-I: any prior or concurrent biologic therapy; for MH-RCT-II: any prior or concurrent biologic therapy other than one first biologic
.
Visit our website for recipes
Contact us
Study PI: Prof. Dan Turner |
[email protected]
Study Management: Gili Focht |
[email protected]
| Luba Plotkin |
[email protected]
Tamar Nave|
[email protected]
| Yonat Aharoni |
[email protected]
נוצר באמצעות
smoove
-
מערכת אוטומציה